1
0
0
(1 - 21 von 21
)
Long-term Safety of Subcutaneous C1-Inhibitor in the Prophylactic...
www.em-consulte.com
H. Henry Li, Timothy J. Craig, DO FAAAAI, Hilary Longhurst, Marco Cicardi, Henrike Feuersenger, Ingo Pragst, PhD, Sarah Mycroft, MD.
Long-term safety and efficacy of subcutaneous C1-inhibitor in ...
findresearcher.sdu.dk
von JA Bernstein · · Zitiert von: 3 — Henrike Feuersenger, PhD zz. ; Ingo Pragst, PhD zz. ; Marc A. Riedl, MD, MS xx. * Allergy Section, Division of Immunology, Department of Internal Medicine, ... › files › 1_s2.0_S10...
Long-term efficacy and safety of subcutaneous C1-inhibitor in women...
aacijournal.biomedcentral.com
von DS Levy · · Zitiert von: 10 — Henrike Feuersenger & Ingo Pragst. Allergy, Immunology and Angioedema Center, Barzilai Medical Center, Ashkelon, Israel. Avner Reshef. Authors: Donald S. Levy, Henriette Farkas, Marc A. Riedl, Florence Ida Hsu, Joel P. Brooks, Marco Cicardi, Henrike Feuersenger, Ingo Pragst and Avner Reshef. › ...
OPUS 4 | Long-term outcomes with subcutaneous C1-inhibitor...
publikationen.ub.uni-frankfurt.de
· ... Donald Levy, Marc A. Riedl, Sandra Christiansen, Henrike Feuersenger, Ingo Pragst, Sarah Mycroft, Dipti Pawaskar, Iris Jacobs.
(PDF) Long-Term Safety of Subcutaneous C1-Inhibitor in the
research.amanote.com
Authors. H. Henry Li Timothy J. Craig Hilary Longhurst Marco Cicardi Henrike Feuersenger Ingo Pragst Sarah Mycroft. Publisher. Elsevier BV. Related search ... › lon...
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1...
healthdocbox.com
... Debra Bensen Kennedy, M.D., Jonathan Edelman, M.D., Henrike Feuersenger, Ph.D., John Philip Lawo, M.Sc., Thomas Machnig, M.D., Dipti Pawaskar, Ph.D., ...
Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric ...
www.liebertpub.com
von D Levy · · Zitiert von: 3 — Henrike Feuersenger, PhD,9 Ingo Pragst, DVM, PhD,9 and Michael E. Manning, MD10. Background: Hereditary angioedema (HAE) due to C1 inhibitor (C1INH) ... › doi › pdf › ped
Presentation: Pharmacokinetic Profile of Subcutaneous C1-Esterase...
aaaai.confex.com
Dipti K. Pawaskar, PhD, Iris Jacobs, MD, Ingo Pragst, MD, Henrike Feuersenger, PhD. RATIONALE: Subcutaneous C1-INH (HAEGARDA®, CSL Behring) at
LongTerm Outcomes with Subcutaneous C 1 Inhibitor ...
slidetodoc.com
... Lawrence B. Schwartz, MD, Joshua Jacobs, MD, Michael Manning, MD, Donald Levy, MD, Marc Riedl, MD, Sandra Christiansen, MD, Henrike Feuersenger, Ph. D, ... › longterm-...
Treatment effect of switching from intravenous to subcutaneous...
pubmed.ncbi.nlm.nih.gov
Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings
Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema...
jhu.pure.elsevier.com
Huamin Li, Sarah Mycroft, Sandra Christiansen, Daniel N. Wood, Henrike Feuersenger, Dipti Pawaskar, Iris Jacobs. Research output: ...
Prevention of hereditary angioedema attacks with a subcutaneous ...
cris.tau.ac.il
... Debra Bensen-Kennedy, Jonathan Edelman, Henrike Feuersenger, John Philip Lawo, Thomas MacHnig, Dipti Pawaskar, Ingo Pragst, Bruce L. Zuraw. › fingerprints
Prophylactic therapy with subcutaneous C1-inhibitor Ebsco
search.ebscohost.com
von T Craig · · Zitiert von: 1 — Timothy Craig, D.O.,1 Henrike Feuersenger, Ph.D.,2 Ingo Pragst, D.V.M., Ph.D.,2 and. John Dang, Pharm.D.3. ABSTRACT. Background: Hereditary angioedema (HAE) ... › login
Prophylactic therapy with subcutaneous C1-inhibitor is associated ...
www.semanticscholar.org
author={Timothy Craig and Henrike Feuersenger and Ingo Pragst and Johnny Dang}, journal={Allergy and asthma proceedings}, year={2022}, volume={43 3}, ... › ...
Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase...
pennstate.pure.elsevier.com
· ... Marco Cicardi, Timothy Craig, Paul K. Keith, Annette Feussner, Henrike Feuersenger, Thomas Machnig, Subhransu Prusty, Ingo Pragst.
MOESM1 of Subcutaneous C1 inhibitor for prevention of attacks of...
figshare.com
· ... Donald Levy, Marc Riedl, Henrike Feuersenger, Subhransu Prusty, Ingo Pragst, Thomas Machnig, Timothy Craig. Additional file 1: Table S1.
Subcutaneous C1 inhibitor for prevention of attacks of ...
europepmc.org
von HH Li · · Zitiert von: 9 — Henrike Feuersenger, . Subhransu Prusty, . › pmc › pm...
Presentation: Long-term Safety of Subcutaneous C1-Inhibitor in the...
aaaai.confex.com
· H. Henry Li, Timothy J. Craig, DO FAAAAI, Hilary Longhurst, Marco Cicardi, Henrike Feuersenger, Ingo Pragst, PhD, Sarah Mycroft, MD.
krankheitslast und psychische komorbiditäten bei patienten ...
ul.qucosa.de
von M Rabe — Henrike Feuersenger, Subhransu Prusty, Ingo Pragst, Thomas Machnig, and Timothy. Craig “Subcutaneous C1 Inhibitor for Prevention of Attacks of ... › api › attachment › ATT-0
Prophylactic therapy with subcutaneous C1-inhibitor is PubMedpubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
· Authors. Timothy Craig , Henrike Feuersenger , Ingo Pragst , John Dang. Affiliations. 1 From the Department of Medicine, Pediatrics and ...
Subcutaneous C1-Esterase Inhibitor [C1-INH(SC)] to Prevent ...
aaaai.confex.com
— ... Timothy J. Craig, DO FAAAAI, Avner Reshef, MD, Henriette Farkas, Henrike Feuersenger, Daniel Wood, PhD, Douglas Watson, Ingo Pragst, PhD. › aaaai
Alle Infos zum Namen "Henrike Feuersenger"
Verwandte Suchanfragen zu Henrike Feuersenger
| Paula Busse Henriette Farkas Sarah Mycroft | Ingo Pragst Marc Riedl Thomas Machnig | John Dang Lilian Varga Dong-In Shin |
Person "Feuersenger" (3) Vorname "Henrike" (2071) Name "Feuersenger" (107) |
sortiert nach Relevanz / Datum